Evaluation of immunomodulatory biomarkers in a pressure overload model of heart failure

Pharmacotherapy

Volumn 27, Issue 4, 2007, Pages 504-509

  Bleske, Barry E ^a   Hwang, Hyun Seok ^a   Zineh, Issam ^b   Ghannam, Michael G ^a   Boluyt, Marvin O ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Animal study; Aortic constriction; Chemokines; Cytokines; Heart failure; Interleukin; Leptin

Indexed keywords

BIOLOGICAL MARKER; EOTAXIN; GAMMA INTERFERON; INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 9; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MYOSIN HEAVY CHAIN BETA; NATRIURETIC FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; BLOOD FLOW VELOCITY; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MARKER; ECHOCARDIOGRAPHY; HEART FAILURE; HEART VENTRICLE OVERLOAD; HEART WEIGHT; IMMUNOMODULATION; MALE; NONHUMAN; NORTHERN BLOTTING; PROTEIN EXPRESSION; RANDOMIZATION; RAT;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; AORTIC COARCTATION; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; BLOTTING, NORTHERN; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FIBRONECTINS; GENE EXPRESSION; HEART FAILURE, CONGESTIVE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKINS; LEPTIN; MALE; MYOSIN HEAVY CHAINS; PRESSURE; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 34047230468     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.27.4.504     Document Type: Article

References (23)

1. Anker SD, von Haehling S. Inflammatory mediators in chronic heart failure: an overview. Heart 2004;90:464-70.
2. Cirrincione GM, Boluyt MO, Hwang HS, Bleske BE. 3-Hydroxy-3-methyl-glytaryl coenzyme A reductase inhibition and extracellular matrix gene expression in the pressure-overloaded rat heart. J Cardiovasc Pharmacol 2006;47:521-30.
3. Boluyt MO, Li ZB, Loyd AM, et al. The mTOR/p70(S6K) signal transduction pathway plays a role in cardiac hypertrophy and influences expression of myosin heavy chain genes in vivo. Cardiovasc Drugs Ther 2004;18:257-67.
4. Boluyt MO, O'Neill L, Meredith AL, et al. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix components. Circ Res 1994;75:23-32.
5. Gullestad L, Aukrust P. Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches. Am J Cardiol 2005;95(suppl):17C-23.
6. Prabhu SD. Cytokine-induced modulation of cardiac function. Circ Res 2004;95:1140-53.
7. Mehra VC, Ramgolam VS, Bender JR. Cytokines and cardiovascular disease. J Leukoc Biol 2005;78:805-18.
8. Long CS. The role of interleukin-1 in the failing heart. Heart Fail Rev 2001;6:81-94.
9. Sato Y, Takatsu Y, Katoka K, et al. Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart decompensation. Clin Cardiol 1999;22:811-13.
10. Blake MJ, Goldman JH, Keeling PJ, Baig MK, Dalgleish AG, McKenna WJ. Abnormal cytokine profiles in patients with idiopathic dilated cardiomyopathy and their asymptomatic relatives. Heart 1996;75:287-90.
11. Naito Y, Tsujino T, Fujioka Y, Ohyanagi M, Okamura H, Iwasaki T. Increased circulating interleukin-18 in patients with congestive heart failure. Heart 2002;88:296-7.
12. Yamaoka M, Yamaguchi S, Okuyama M, Tomoike H. Anti-inflammatory cytokine profile in human heart failure. Jpn Circ J 1999;63:951-6.
13. Cain BS, Meldrum DR, Dinarello CA, et al. Tumor necrosis factor-α and interleukin-1β synergistically depress human myocardial function. Crit Care Med 1999;27:1309-18.
14. Schreur KD, Liu S. Involvement of ceramide in inhibitory-effect of IL-1β on L-type calcium current in adult rat ventricular myocytes. Am J Physiol 1997;272:H2591-8.
15. Sugishita K, Kinugawa K, Shimizu T, et al. Cellular basis for the acute inhibitory effects of IL-6 and TNF-α on excitation-contraction coupling. J Mol Cell Cardiol 1999;31:1457-67.
16. McGowan FX, Takeuchi K, del Nido PJ, Davis PJ, Lancaster JR, Hattler BG. Myocardial effects of interleukin-2. Transplant Proc 1994;26:209-10.
17. Gulick T, Chung MK, Pieper SJ, Lange LG, Schreiner GF. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness. Proc Natl Acad Sci 1989;86:6753-7.
18. Cao CM, Xia Q, Bruce IC, et al. Influence of interleukin-2 on calcium handling in rat ventricular myocytes. J Mol Cell Cardiol 2003;35:1491-503.
19. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
20. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin-10. J Exp Med 1991;174:1549-55.
21. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993;11:165-90.
22. Voll RE, Hermman M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature 1997;390:350-1.
23. Baumgarten G, Knuefermann P, Kalra D, et al. Load-dependent and -independent regulation of proinflammatory cytokine and cytokine receptor gene expression in the adult mammalian heart. Circulation 2002;105:2192-7.